Trades on 2 secondary markets

Auron Therapeutics

Auron Therapeutics is a clinical-stage biotechnology company headquartered in Newton, Massachusetts, developing therapies that target cell-state plasticity to address the underlying causes of disease across oncology and inflammatory disease indications. The company built the AURIGIN platform, which

minimal 13.9 / 100 0 APIs View provider profile →
CompanyBiotechnologyPharmaceuticalsOncologyDrug DiscoveryComputational Biology

Auron Therapeutics is an API provider whose private shares are listed on 2 secondary markets: EquityZen, Nasdaq Private Market.

Where It Trades

EZ EquityZen View listing → N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.